Drug Shortage Report for MAR-ABIRATERONE
| Report ID | 254001 |
| Drug Identification Number | 02503980 |
| Brand name | MAR-ABIRATERONE |
| Common or Proper name | MAR-Abiraterone 250mg |
| Company Name | MARCAN PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ABIRATERONE ACETATE |
| Strength(s) | 250MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 120 |
| ATC code | L02BX |
| ATC description | HORMONE ANTAGONISTS AND RELATED AGENTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2025-04-04 |
| Actual start date | 2025-04-04 |
| Estimated end date | 2025-05-30 |
| Actual end date | 2025-05-01 |
| Shortage status | Resolved |
| Updated date | 2025-05-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2025-05-02 | English | Compare |
| v5 | 2025-05-01 | French | Compare |
| v4 | 2025-05-01 | English | Compare |
| v3 | 2025-04-05 | English | Compare |
| v2 | 2025-04-03 | French | Compare |
| v1 | 2025-04-03 | English | Compare |
Showing 1 to 6 of 6